Abiomed, Inc. (NASDAQ:ABMD – Get Rating) was the target of a large drop in short interest during the month of August. As of August 15th, there was short interest totalling 1,550,000 shares, a drop of 9.4% from the July 31st total of 1,710,000 shares. Currently, 3.5% of the shares of the company are short sold. […]
Zurcher Kantonalbank Zurich Cantonalbank increased its position in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 20.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 9,852 shares of the medical equipment provider’s stock after acquiring an additional 1,647 shares during […]
State of Alaska Department of Revenue cut its stake in Abiomed, Inc. (NASDAQ:ABMD – Get Rating) by 10.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 21,367 shares of the medical equipment provider’s stock after selling 2,625 shares during […]
Abiomed, Inc. (NASDAQ:ABMD – Get Rating) has been assigned an average rating of “Hold” from the seven brokerages that are covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and one has issued a buy recommendation on the company. The average […]
Abiomed (NASDAQ:ABMD – Get Rating) and TELA Bio (NASDAQ:TELA – Get Rating) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, institutional ownership, earnings, profitability, dividends, valuation and analyst recommendations. Risk & Volatility Abiomed has a beta of 1.34, suggesting that […]